Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin effects on bone, bone marrow, sleep, and arterial stiffness in postmenopausal women
2020-002934-34Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of melatonin in osteoporosis, postmenopausal osteoporosis and Endocrinopathy, sponsored by Aarhus University Hospital. Primary endpoint: Changes in gene expression in mesenchymal stem cells. Started Sep 2020; status: completed.
02
Drugs
melatonin
03
Conditions
osteoporosispostmenopausal osteoporosisEndocrinopathy
Beyond the preview
Go deeper on 2020-002934-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002934-34.